VCTDSA联合CT灌注成像在急性缺血性卒中诊断运用探究

目的：探讨64层容积CT数字减影血管造影（Volume computed tomography digital subtraction angiography, VCTDSA）联合CT灌注成像在急性缺血性卒中诊断价值。方法：回顾性分析45例临床确诊为急性缺血性卒中患者的临床资料,分别给予VCTDSA与CT灌注成像处理,分析这两种技术对急性缺血性卒中患者的诊断敏感性和特异性。结果：45例患者检查有颅内有不同部位出血灶,多见于脑室,均伴有不同程度的异常血管网形成,其中VCTDSA图像质量优于CT灌注成像,VCTDSA较DSA可准确显示和测量动静脉瘘口大小,VCTDSA与MRA在瘤体长轴、瘤颈的比较中无显著性差异。结论：与其他减影CTA比较,VCTDSA联合CT灌注成像在急性缺血性卒中患者的诊断中具有优势。     

冠状动脉CT造影对冠心病的临床诊断价值研究

目的:探讨研究冠状动脉CT造影检查对冠心病的临床诊断价值。方法:收集我院2012年1月至2013年10月共计70例临床怀疑为冠心病的患者,对这些患者分别进行冠状动脉CT造影检查和数字减影冠状动脉造影(DSA)检查,记录这两项检查所得结果及数据,以检查数据为基础对冠状动脉CT造影和数字减影冠状动脉造影检查的临床实验效果进行对比研究。结果:70例病人均可顺利完成以上两种检查,按照数字减影冠状动脉造影检查的标准,冠状动脉CT造影的敏感度为92.2%,特异度为97.4%、阳性预测率为90.5%、阴性预测率98%。结论:相对于数字减影冠状动脉造影检查,冠状动脉CT造影检查是一种更加安全、可靠、无创且更具临床指导意义的检测技术,因此可以推荐作为冠心病诊断的首选方法。     

冠状动脉CT造影对冠心病的临床诊断价值研究

目的：探讨研究冠状动脉CT造影检查对冠心病的临床诊断价值。方法：收集我院2012年1月至2013年10月共计70例临床怀疑为冠心病的患者,对这些患者分别进行冠状动脉CT造影检查和数字减影冠状动脉造影（DSA）检查,记录这两项检查所得结果及数据,以检查数据为基础对冠状动脉CT造影和数字减影冠状动脉造影检查的临床实验效果进行对比研究。结果：70例病人均可顺利完成以上两种检查,按照数字减影冠状动脉造影检查的标准,冠状动脉CT造影的敏感度为92.2%,特异度为97.4%、阳性预测率为90.5%、阴性预测率98%。结论：相对于数字减影冠状动脉造影检查,冠状动脉CT造影检查是一种更加安全、可靠、无创且更具临床指导意义的检测技术,因此可以推荐作为冠心病诊断的首选方法。     

宝石能谱CT的功能特点及心血管检查的临床应用

宝石能谱CT拥有一系列独特的技术,包括宝石探测器、高压发射器、ASIR重组技术、能谱栅技术等,使其具有低剂量高清成像、能谱成像和动态500排成像特点,实现了全身0.23mm的极限空间分辨率和类MRI的软组织低密度分辨率,为心脏能量成像、斑块性质的鉴别及金属伪影的消除提供了全新有效的手段。其特有的高纯度和高通透性的物理学特性,再加上影像链中采样率的增高,专有的高清算法,使得宝石能谱CT能够在更低的剂量下,获得更为清晰的图像质量,达到目前业内最高的空间分辨率和密度分辨率;同时,其独有的能谱栅成像技术,将CT诊断从形态学带入功能学领域,因此也被称为"显微CT,病理CT,绿色CT",宝石能谱CT代表了目前CT发展的趋势,它用准确的绝对CT值的单能量成像(keV)诊断和基物质成像诊断来取代传统的相对CT值的混合能量(kVp)成像诊断,用多参数CT成像诊断来代替传统的单参数CT成像诊断,而"三同"(同时、同源、同向)的物理基础保证了其能谱成像的准确性,使CT能谱成像真正走入了临床诊断的第一线,从而提高了心血管疾病诊断的准确性和安全性。为CT在心脏疾病的诊断方面开拓了新领域和新方法。     

数字减影血管造影设备的维护与维修

数字减影血管造影设备是大型医学影像仪器,在临床诊断及治疗发挥着重要的作用。因此,及时的维护和规范的保养是降低设备故障,减少维修成本,提高工作效率的关键。本文对我院数字减影血管造影设备的保养工作展开回顾,分析临床工作中常见的设备故障,并总结实用的维护、保养方法,为有效利用设备资源提供参考。     

时间减影在静脉肾盂造影中的应用价值研究

目的探讨数字X线机(DFR)时间减影对静脉肾盂造影的诊断价值,并与常规单纯DFR静脉肾盂造影比较。方法对38例运用数字(DFR)静脉肾盂造影的检查者,同时采用时间减影进行分析。检查结果正常16例,肾盂积水、肾结石、输尿管畸形、输尿管结石等22例。结论数字静脉肾盂造影检查 时间减影检查,较好地克服了传统造影方法的不足,为泌尿系统的诊断和治疗提供了更全面和确切的依据,取得了较好的临床效果。     

肝脏能谱CT虚拟平扫成像替代传统CT平扫成像可行性研究

目的:探讨肝脏能谱CT虚拟平扫成像替代传统CT平扫成像可行性,以供参考。方法:随机选取2013年6月至2014年6月我院已确诊的肝脏疾病患者49例作为研究对象,将2种不同的扫描成像方法分为2组,对照组:对49例患者采用传统CT平扫成像的方式进行肝脏扫描成像分析;实验组:对49例患者采用肝脏能谱CT虚拟平扫成像的方式进行肝脏扫描成像分析。2组成像结果出来之后统一交给经验丰富的影像诊断小组,并由诊断小组对2种影像进行噪声、伪影、病灶检测能力三方面进行主观对比评价、分析。结果:肝脏能谱CT虚拟平扫成像的平均噪声为2.18±0.58,平均伪影为1.57±0.38,而患者的平均吸收剂量为10.16±2.57;传统CT平扫成像的平均噪声为1.68±0.37,平均伪影为1.44±0.24,而患者的平均吸收剂量为20.06±4.47。且2组差异具有统计学意义(p0.05)。结论:肝脏能谱CT虚拟平扫成像可以代替传统CT平扫成像进行肝脏检查,且具有良好的诊断价值。     

盆腔疾病髂内动脉栓塞术的研究进展

髂内动脉栓塞是盆腔出血性疾病和肿瘤治疗的重要治疗方法,常规采用Seldinger技术,从一侧股动脉径路两侧髂内动脉选择性与超选择性插管。髂内动脉是盆腔脏器主要供血来源,根据数字减影动脉造影术（Digital subtraction arteriography,DSA）功能可分为：常规DSA,旋转DSA,平板数字减影旋转血管造影与三维血管重建和路图技术。栓塞剂可分为颗粒型和液态型栓塞剂。本文综述了盆腔疾病髂内动脉栓塞术近年来的研究进展。     

三维DSA在颅内动脉瘤中的应用

目的探讨三维数字减影血管造影(3D DSA)在颅内动脉瘤中的应用价值。方法使用GE Innova 3100平板血管造影机对40例疑似颅内动脉瘤患者行双侧颈内、外动脉和双侧椎动脉正、侧位2D DSA,进一步对感兴趣血管行3D DSA,通过容积再现(VR)进行颅内血管重建。结果 3D DSA检出39例动脉瘤患者,47枚动脉瘤,2D DSA检出31例动脉瘤患者,35枚动脉瘤,二者检出动脉瘤的长、短径无统计学差异(P>0.05),图像质量有统计学差异(P<0.05)。2D DSA出现假阳性动脉瘤3枚,假阴性动脉瘤15枚,评估颅内动脉瘤的灵敏度为78.9%,特异性为85.2%;3D DSA没有出现假阳性、假阴性动脉瘤,评估颅内动脉瘤的灵敏度为100%,特异性为100%。在动脉瘤形态、瘤颈尺寸及与相邻血管间的关系的显示上,3D DSA明显优于2D DSA。结论 3D DSA作为脑动脉造影中2D DSA的进一步补充,对颅内动脉瘤的诊断与治疗具有重要价值。     

盆腔疾病骸内动脉栓塞术的研究进展

骼内动脉栓塞是盆腔出血性疾病和肿瘤治疗的重要治疗方法,常规采用Seldinger技术,从一侧股动脉径路两侧骼内动脉选择性与超选择性插管.骼内动脉是盆腔脏器主要供血来源,根据数字减影动脉造影术(Digital subtraction arteriography,DSA)功能可分为:常规DSA,旋转DSA,平板数字减影旋转血管造影与三维血管重建和路图技术.检塞剂可分为颗粒型和液态型栓塞剂.本文综述了盆腔疾病骼内动脉检塞术近年来的研究进展.     

基于Visual C#语言的DICOM标准医学图像的显示和实现

介绍DICOM3.0医学图像文件的格式和C#语言的特点,首次利用Visual C#语言对该标准的图像进行显示和处理,能够直接读取DICOM格式原始图像数据,并可批量转换成BMP等格式进行处理,此项工作可为医学图像处理研究及相关医学图像软件开发奠定基础。     

梗阻性低位直肠癌保肛手术可行性探讨

目的：探讨梗阻性低位直肠癌保肛治疗（直肠癌前切除术（dixon手术））的可行性及术后肠瘘的防治。方法：回顾性分析我科2009年1月．2012年1月梗阻性低位直肠癌的保肛治疗（dixon）24例手术患者（梗阻性保肛组）临床资料及非梗阻性低位直肠癌保肛治疗（dixon）的24例患者（非梗阻性保肛组）临床资料,比较梗阻性与非梗阻性低位肠梗阻保肛治疗的临床疗效,分析梗阻性低位肠梗阻保肛治疗的可行性。结果：梗阻性保肛组住院天数：11．9天,非梗阻性肠梗阻保肛组8．7天P〈0．05;梗阻性保肛纽发生肠瘘：4例（16．7％）,非梗阻性肠梗阻保肛组发生肠瘘：1例（4.2％）P〈0．05,经充分引流后肠痿愈合,无1人死亡,两组术后至出院期间死亡人数：0例;梗阻性保肛组肠功能恢复（以排气排便为指标）：5．1天,非梗阻性保肛组肠功能恢复：3．8天,P〈0．05;术后6个月腹泻便秘患者两组相同为24人;术后6个月梗阻性保肛组肿瘤复发6人（25％）,非梗阻性保肛组肿瘤复发5人（20．8％）,P〉0．05。结论：梗阻性低位肠梗阻保肛治疗住院期疗效较非梗阻性保肛组差,中远期疗效无明显差异。梗阻性低位直肠癌可行保肛治疗。     

DICOM-RT Ion interface to utilize MC simulations in routine clinical workflow for proton pencil beam radiotherapy

To adopt Monte Carlo (MC) simulations as an independent dose calculation method for proton pencil beam radiotherapy, an interface that converts the plan information in DICOM format into MC components such as geometries and beam source is a crucial element. For this purpose, a DICOM-RT Ion interface (https://github.com/topasmc/dicom-interface) has been developed and integrated into the TOPAS MC code to perform such conversions on-the-fly. DICOM-RT objects utilized in this interface include Ion Plan (RTIP), Ion Beams Treatment Record (RTIBTR), CT image, and Dose. Beamline geometries, gantry and patient coordinate systems, and fluence maps are determined from RTIP and/or RTIBTR. In this interface, DICOM information is processed and delivered to a MC engine in two steps. A MC model, which consists of beamline geometries and beam source, to represent a treatment machine is created by a DICOM parser of the interface. The complexities from different DICOM types, various beamline configurations and source models are handled in this step. Next, geometry information and beam source are transferred to TOPAS on-the-fly via the developed TOPAS extensions. This interface with two treatment machines was successfully deployed into our automated MC workflow which provides simulated dose and LET distributions in a patient or a water phantom automatically when a new plan is identified. The developed interface provides novel features such as handling multiple treatment systems based on different DICOM types, DICOM conversions on-the-fly, and flexible sampling methods that significantly reduce the burden of handling DICOM based plan or treatment record information for MC simulations.     

imzML--a common data format for the flexible exchange and processing of mass spectrometry imaging data

The application of mass spectrometry imaging (MS imaging) is rapidly growing with a constantly increasing number of different instrumental systems and software tools. The data format imzML was developed to allow the flexible and efficient exchange of MS imaging data between different instruments and data analysis software. imzML data is divided in two files which are linked by a universally unique identifier (UUID). Experimental details are stored in an XML file which is based on the HUPO-PSI format mzML. Information is provided in the form of a 'controlled vocabulary' (CV) in order to unequivocally describe the parameters and to avoid redundancy in nomenclature. Mass spectral data are stored in a binary file in order to allow efficient storage. imzML is supported by a growing number of software tools. Users will be no longer limited to proprietary software, but are able to use the processing software best suited for a specific question or application. MS imaging data from different instruments can be converted to imzML and displayed with identical parameters in one software package for easier comparison. All technical details necessary to implement imzML and additional background information is available at www.imzml.org.     

梗阻性低位直肠癌保肛手术可行性探讨

目的:探讨梗阻性低位直肠癌保肛治疗(直肠癌前切除术(dixon手术))的可行性及术后肠瘘的防治。方法:回顾性分析我科2009年1月-2012年1月梗阻性低位直肠癌的保肛治疗(dixon)24例手术患者(梗阻性保肛组)临床资料及非梗阻性低位直肠癌保肛治疗(dixon)的24例患者(非梗阻性保肛组)临床资料,比较梗阻性与非梗阻性低位肠梗阻保肛治疗的临床疗效,分析梗阻性低位肠梗阻保肛治疗的可行性。结果:梗阻性保肛组住院天数:11.9天,非梗阻性肠梗阻保肛组8.7天P0.05;梗阻性保肛组发生肠瘘:4例(16.7%),非梗阻性肠梗阻保肛组发生肠瘘:1例(4.2%)P0.05,经充分引流后肠瘘愈合,无1人死亡,两组术后至出院期间死亡人数:0例;梗阻性保肛组肠功能恢复(以排气排便为指标):5.1天,非梗阻性保肛组肠功能恢复:3.8天,P0.05;术后6个月腹泻便秘患者两组相同为24人;术后6个月梗阻性保肛组肿瘤复发6人(25%),非梗阻性保肛组肿瘤复发5人(20.8%),P0.05。结论:梗阻性低位肠梗阻保肛治疗住院期疗效较非梗阻性保肛组差,中远期疗效无明显差异。梗阻性低位直肠癌可行保肛治疗。     

Simplified Generation of Biomedical 3D Surface Model Data for Embedding into 3D Portable Document Format (PDF) Files for Publication and Education

The usefulness of the 3D Portable Document Format (PDF) for clinical, educational, and research purposes has recently been shown. However, the lack of a simple tool for converting biomedical data into the model data in the necessary Universal 3D (U3D) file format is a drawback for the broad acceptance of this new technology. A new module for the image processing and rapid prototyping framework MeVisLab does not only provide a platform-independent possibility to create surface meshes out of biomedical/DICOM and other data and to export them into U3D – it also lets the user add meta data to these meshes to predefine colors and names that can be processed by a PDF authoring software while generating 3D PDF files. Furthermore, the source code of the respective module is available and well documented so that it can easily be modified for own purposes.     

CT、常规MRI序列和SWI诊断弥漫性轴索脑损伤比较

目的：探讨弥漫性轴索损伤（DAI）的CT、常规MRI序列和磁敏感加权成像（SWI）表现与诊断价值。方法：回顾分析42例DAI患者的影像资料,分析、比较CT、MRI和SWI的信号特征及脑内病灶显示率。结果：SWI显示病灶最多、最敏感;脑CT扫描次之;常规MRI序列敏感性差,只有部分病灶显示。结论：CT、MRI和SWI对DAI早期诊断、治疗及评价预后具有重要参考价值,SWI是诊断DAI最有效的首选影像学检查方法。     

A cloud-fog software architecture for dental CBCT dose monitoring using the DICOM structured report: Automated establishment of DRL

PurposeThe diagnostic reference level (DRL) has been established to optimize the diagnostic methods and reduce radiation dose during radiographic examinations. The aim of this study was to present a completely new solution based on Cloud-Fog software architecture for automatic establishment of the DRL values during dental cone-beam computed tomography (CBCT) according to digital imaging and communications in medicine (DICOM) structured reports.Methods and MaterialsA Cloud-Fog software architecture was used for automatic data handling. This architecture used the DICOM structured reports as a source for extracting the required information by fog devices in the imaging center. These devices transferred the derived information to the cloud server. The cloud server calculated the value of indication-based DRL in dental CBCT imaging based upon the parameters and adequate quantities of the absorbed dose. The feedback of DRL value was continuously announced to the imaging centers in 6 phases. In each phase, the level of the dose was optimized in imaging centers.ResultsThe DRL value was established for 5-specific indications, including third molar teeth (511 mGy.cm²), implant (719 mGy.cm²), form and position anomalies of the tooth (408 mGy.cm²), dentoalveolar pathologies (612 mGy.cm²), and endodontics (632 mGy.cm²). The determination of the DRL value in each phase revealed a downward trend until stabilization.ConclusionThe new solution presented in this study makes it possible to calculate and update the DRL value nationally and automatically among all centers. Also, the results showed that this approach is successful in establishing stabilized DRL values.     

Java Treeview--extensible visualization of microarray data

Open source software encourages innovation by allowing users to extend the functionality of existing applications. Treeview is a popular application for the visualization of microarray data, but is closed-source and platform-specific, which limits both its current utility and suitability as a platform for further development. Java Treeview is an open-source, cross-platform rewrite that handles very large datasets well, and supports extensions to the file format that allow the results of additional analysis to be visualized and compared. The combination of a general file format and open source makes Java Treeview an attractive choice for solving a class of visualization problems. An applet version is also available that can be used on any website with no special server-side setup.